Villarta, Baby Boy -.
HRN: 22-19-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2022
AMPICILLIN 250MG (VIAL)
11/12/2022
11/19/2022
IV
130mg
Q12h
PSNB, Thinly MSAF, ER Delivery
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes